Dr Boitumelo Semete Makokotlela

Boitumelo is the CEO of the South African Health Products Regulatory Authority that is tasked with overseeing access to safe, quality and effective health products, as well as oversight for clinical trial conducted in South Africa. She has a Ph.D. (Biochemistry) and holds MSc in Management Finance and Investment. She is the chair of the African Medicines Regulatory Harmonization (AMRH) initiative, where she leads the steering committee responsible for ensuring development and implementation of harmonized regulatory requirements across the continent. The AMRH, is a critical foundational platform for the established of the African Medicines Agency.

She has a wealth of experience on the African continent having been involved a number of thought leadership projects such as the African Union Strategy for Health Research, the East Africa Community Bioeconomy strategy development team and WHO Afro Expert Panel on scaling health Innovations in Africa. She was also a member of the South African Ministerial Advisory Committee on COVID-19 at the National Department of Health.

Within the technology innovation space, she was the Executive Director at CSIR Biosciences and before that she managed a biotechnology incubator at The Innovation Hub Management Company. She was with McKinsey & Company for 2 years as a McKinsey Leadership Fellow and is also a fellow of the African Leadership Initiative.

She has extensive research experience gained during her tenure at the CSIR as a Senior Researcher. She completed her postdoctoral research at the University of Nottingham and EPFL, Switzerland. She has published as a first author and co-author in scientific publications, review articles and book chapters. She sits on several scientific advisory committees and Board of Directors.